These presentations are expected to provide Neurizon with increased international visibility and robust additional data to support ongoing partnering discussions and the clinical development pathway for NUZ-001.We are indebted to Dr Lee’s team for performing and assembling the data in time for the conference, considering the challenges posed by the recent tropical cyclone threat in Queensland. We look forward to our continued collaboration and await with excitement the near-term readouts from the mouse model of Parkinson’s disease.”
Ann: NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $78.76M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.0¢ | $78.77K | 503.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 240870 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 377391 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |